December 28, 2012 at 18:12 PM EST
Leading Stocks Fall; Valeant Slides Below Buy Point
Most leading stocks fell Friday as Washington remained deadlocked in a final effort to avert the fiscal cliff. Valeant Pharmaceuticals (VRX) slipped below its buy point. Valeant, which makes drugs to treat nervous system disorders, fell 0.81 to end at 58.87, sinking below its 59.10 buy point from a double-bottom base. Volume was well below average. The stock has fallen for five straight sessions and had briefly dipped below the buy point
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here